【poem for whom the bell tolls】Taking A Look At Garofalo Health Care S.p.A.’s (BIT:GHC) ROE
While some investors are already well versed in financial metrics (hat tip),poem for whom the bell tolls this article is for those who would like to learn about Return On Equity (ROE) and why it is important. To keep the lesson grounded in practicality, we’ll use ROE to better understand Garofalo Health Care S.p.A. (
BIT:GHC
).
Our data shows
Garofalo Health Care has a return on equity of 14%
for the last year. One way to conceptualize this, is that for each €1 of shareholders’ equity it has, the company made €0.14 in profit.
See our latest analysis for Garofalo Health Care
How Do I Calculate Return On Equity?
The
formula for return on equity
is:
Return on Equity = Net Profit ÷ Shareholders’ Equity
Or for Garofalo Health Care:
14% = 15.049 ÷ €111m (Based on the trailing twelve months to June 2018.)
It’s easy to understand the ‘net profit’ part of that equation, but ‘shareholders’ equity’ requires further explanation. It is the capital paid in by shareholders, plus any retained earnings. The easiest way to calculate shareholders’ equity is to subtract the company’s total liabilities from the total assets.
What Does ROE Signify?
ROE measures a company’s profitability against the profit it retains, and any outside investments. The ‘return’ is the profit over the last twelve months. A higher profit will lead to a higher ROE. So, all else equal,
investors should like a high ROE
. That means it can be interesting to compare the ROE of different companies.
Does Garofalo Health Care Have A Good ROE?
Arguably the easiest way to assess company’s ROE is to compare it with the average in its industry. However, this method is only useful as a rough check, because companies do differ quite a bit within the same industry classification. If you look at the image below, you can see Garofalo Health Care has a similar ROE to the average in the Healthcare industry classification (14%).
BIT:GHC Last Perf January 1st 19
That’s neither particularly good, nor bad. ROE can give us a view about company quality, but many investors also look to other factors, such as whether there are insiders buying shares. If you like to buy stocks alongside management, then you might just love this
free
list of companies. (Hint: insiders have been buying them).
Why You Should Consider Debt When Looking At ROE
Companies usually need to invest money to grow their profits. That cash can come from retained earnings, issuing new shares (equity), or debt. In the case of the first and second options, the ROE will reflect this use of cash, for growth. In the latter case, the debt required for growth will boost returns, but will not impact the shareholders’ equity. Thus the use of debt can improve ROE, albeit along with extra risk in the case of stormy weather, metaphorically speaking.
Story continues
Combining Garofalo Health Care’s Debt And Its 14% Return On Equity
Garofalo Health Care has a debt to equity ratio of 0.45, which is far from excessive. The fact that it achieved a fairly good ROE with only modest debt suggests the business might be worth putting on your watchlist. Conservative use of debt to boost returns is usually a good move for shareholders, though it does leave the company more exposed to interest rate rises.
In Summary
Return on equity is useful for comparing the quality of different businesses. In my book the highest quality companies have high return on equity, despite low debt. All else being equal, a higher ROE is better.
Having said that, while ROE is a useful indicator of business quality, you’ll have to look at a whole range of factors to determine the right price to buy a stock. It is important to consider other factors, such as future profit growth — and how much investment is required going forward. So you might want to check this FREE
visualization of analyst forecasts for the company
.
But note:
Garofalo Health Care may not be the best stock to buy
. So take a peek at this
free
list of interesting companies with high ROE and low debt.
To help readers see past the short term volatility of the financial market, we aim to bring you a long-term focused research analysis purely driven by fundamental data. Note that our analysis does not factor in the latest price-sensitive company announcements.
The author is an independent contributor and at the time of publication had no position in the stocks mentioned. For errors that warrant correction please contact the editor at
.
View comments
-
Tokyo 2020 Wheelchair rugby test event canceled over coronavirus concernsWednesday’s ETF Chart To Watch: VGK Drifting Towards Support Ahead Of Eurozone GDPIs WMFAX a Strong Bond Fund Right Now?Riverdale recap: A fog forces some serious conversationsCar rental firm Hertz gets more time from lenders to avoid bankruptcyCardinal Health (CAH) Beats on Earnings & Revenues in Q4Ryanair to move Copenhagen-based aircraft after court rulingWhy Vita Life Sciences Limited (ASX:VLS) Looks Like A Quality CompanyHow Does TCF Financial's (NASDAQ:TCF) P/E Compare To Its Industry, After The Share Price Drop?Fatalities on commercial passenger aircraft rise in 2018
下一篇:GBP/USD Price Forecast – British Pound Continues to Struggle at Same Level
- ·Exclusive: U.S. sanctions have idled a quarter of Iranian oil rigs
- ·Chloé Zhao is 2nd woman to win best director prize at Globes
- ·Singapore fourth quarter GDP growth cools as trade woes darken outlook
- ·How Does Investing In RTC Group plc (LON:RTC) Impact The Volatility Of Your Portfolio?
- ·LATAM Airlines Group: Q1 Earnings Insights
- ·GOGL - Repurchase of shares
- ·Is HealthEquity (HQY) Outperforming Other Medical Stocks This Year?
- ·Netflix under pressure, Crocs gets an upgrade, Google receives FCC approval
- ·HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Urges Opera Limited (OPRA) Investors With Losses to Contact its Attorneys: Important Class Action Deadline Approaching
- ·Former Judge Randy Wilson Returns to Susman Godfrey After 15 Years on Bench
- ·Deferred Interest, Waived Interest -- Why You Need to Know the Terms of Your 0% APR Offer
- ·Why Vita Life Sciences Limited (ASX:VLS) Looks Like A Quality Company
- ·Interactive Brokers' (IBKR) October DARTs Up on Higher Trading
- ·Boeing Is Set to Beat Airbus in the 2018 Order Race
- ·BRIEF-China Yangtze Power Says 2018 Power Generation Up 2.2 Percent Y/Y
- ·BRIEF-CCOOP Group's 2018 Profit Benefits From Government Subsidies
- ·Ra Medical Systems, Inc. to Host Earnings Call
- ·The center of the Milky Way looks like a work of art
- ·B+S Banksysteme Aktiengesellschaft (FRA:DTD2) Has A ROE Of 8.1%
- ·Could The Pashupati Cotspin Limited (NSE:PASHUPATI) Ownership Structure Tell Us Something Useful?
- ·Monthly Outlook – January 2020
- ·Why RPC Group Plc (LON:RPC) Is A Top Dividend Stock
- ·Colbert Figures Out How to Make Coronavirus Quarantine Feel Like a Vacation, Literally (Video)
- ·Ten Key Components to Sustaining a Small Law Firm
- ·LIVE BLOG: How businesses are responding to coronavirus outbreak
- ·Cayan to Debut Industry-Changing Solutions at RetailNOW 2016
- ·Barr Finds No Election Fraud as DOJ Pursues ‘Bribery for Pardons’ Scheme
- ·Why PVP Ventures Limited’s (NSE:PVP) CEO Pay Matters To You
- ·Could The Pashupati Cotspin Limited (NSE:PASHUPATI) Ownership Structure Tell Us Something Useful?
- ·EUR/USD Price Forecast – EURO Declines On Dovish Outlook
- ·SEC delays decision on tZERO’s proposed security token exchange
- ·3 Hotel Stocks Likely to Beat Estimates in Q1 Earnings
- ·Thousands march in Hong Kong against China repression after grim 2018
- ·Mark Zuckerberg's vision of the future is full of artificial intelligence, telepathy, and virtual reality
- ·Retail sector companies turn to masks, gloves in coronavirus fight
- ·As US questions free trade, EU and Japan usher in new deal